For: | Yang YQ, Wen ZY, Liu XY, Ma ZH, Liu YE, Cao XY, Hou L, Xie H. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(2): 129-150 [PMID: 36926237 DOI: 10.4254/wjh.v15.i2.129] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i2/129.htm |
Number | Citing Articles |
1 |
Mingyang Du, Yonggang Qu, Lingshan Qin, Jiahe Zheng, Wei Sun. The cell death‐related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18168
|
2 |
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, James Korolewicz, Matthias Pinter, Alessandra Gennari, Francesco Mauri, Mario Pirisi, Rosalba Minisini, Federica Vincenzi, Michela Burlone, Cristina Rigamonti, Matteo Donadon, Giuseppe Cabibbo, Antonio D'Alessio, David James Pinato. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1955 doi: 10.2147/JHC.S291553
|
3 |
Xiaoan Qi, Liang Liu. The regulatory effect of lncRNA LINC00943 on the progression of hepatocellular carcinoma and its relationship with clinicopathological features. Clinics and Research in Hepatology and Gastroenterology 2024; 48(2): 102273 doi: 10.1016/j.clinre.2023.102273
|
4 |
Takashi Ishida, Atsushi Miki, Yasunaru Sakuma, Jun Watanabe, Kazuhiro Endo, Hideki Sasanuma, Takumi Teratani, Joji Kitayama, Naohiro Sata. Preoperative Bone Loss Predicts Decreased Survival Associated with Microvascular Invasion after Resection of Hepatocellular Carcinoma. Cancers 2024; 16(11): 2087 doi: 10.3390/cancers16112087
|